CEOInterviews.AI
Verified executive transcripts, quotes, and interview insights from Latigo Biotherapeutics leadership.
Developer of non-opioid NaV1.8 inhibitors for pain. [BIOTECH-2026-10-04]
Search transcripts, quotes, and verified statements from every Latigo Biotherapeutics executive via our platform or API.